Single center prospective evaluation of Ga-68-PSMA-11 in the US with one-year follow-up correlation
Conclusions: 68Ga-PSMA-11 PET is sensitive for prostate cancer metastases in patients with biochemically recurrent prostate cancer, with high positive predictive value and excellent inter-rater reliability.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Lawhn Heath, C., Tao, D., Greene, K., Feng, F., Ryan, C., Small, E., Carroll, P. Tags: Prostate Posters Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Legislation | Nuclear Medicine | Pathology | Prostate Cancer | Radiation Therapy | Radiology | Study